Retraction Notice to “Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study” (Am J Kidney Dis., (2016) 55(2) (291–299) (S0272638609014474) (10.1053/j.ajkd.2009.10.049));Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study

American Journal of Kidney Diseases

Volumn 55, Issue 2, 2010, Pages 291-299

  Jamal, Sophie A ^a   Swan, Victoria J D ^b   Brown, Jacques P ^c   Hanley, David A ^d   Prior, Jerilynn C ^e   Papaioannou, Alexandra ^f   Langsetmo, Lisa ^g   Josse, Robert G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

bone loss; bone mineral density; Impaired kidney function; osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CAFFEINE; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; AGEISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY WEIGHT; BONE DENSITY; CALCIUM BLOOD LEVEL; CANADA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; FEMUR NECK; FOOD INTAKE; FRACTURE; GLOMERULUS FILTRATION RATE; HIP; HUMAN; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SELF CONCEPT; SELF REPORT; SEX DIFFERENCE; SITTING; VITAMIN BLOOD LEVEL;

EID: 74449093166     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.06.005     Document Type: Erratum

References (38)

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
2. Jamal S. Fractures in men and women with dialysis-dependent renal failure. Endocrinol Rounds 3 (2003) 1-6
3. Jamal S.A., Gilbert J., Gordon C., and Bauer D.C. Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21 (2006) 543-548
4. Jamal S.A., Leiter R.E., Jassal V., Hamilton C.J., and Bauer D.C. Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporosis Int 17 (2006) 1390-1397
5. Malluche H.H., and Faugere M.C. Renal osteodystrophy. N Engl J Med 321 (1989) 317-318
6. Lindberg J.S., and Moe S.M. Osteoporosis in end-state renal disease. Semin Nephrol 19 (1999) 115-122
7. Atsumi K., Kushida K., Yamazaki K., Shimizu S., Ohmura A., and Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33 (1999) 287-293
8. Chan Y.L., Furlong T.J., Cornish C.J., and Posen S. Dialysis osteodystrophy. A study involving 94 patients. Medicine (Baltimore) 64 (1985) 296-309
9. Schaab P.C., Murphy G., Tzamaloukas A.H., et al. Femoral neck fractures in patients receiving long-term dialysis. Clin Orthop 260 (1990) 224-231
10. Vonesh E.F., and Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 10 (1999) 354-365
11. Eknoyan G. Cardiovascular mortality and morbidity in dialysis patients. Miner Electrolyte Metab 25 (1999) 100-104
12. Coco M., and Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36 (2000) 1115-1121
13. Jamal S.A., Hayden J.A., and Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 49 (2007) 674-681
14. Yamaguchi T., Kanno E., Tsubota J., Shiomi T., Nakai M., and Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19 (1996) 549-555
15. Fontaine M.A., Albert A., Dubois B., Saint-Remy A., and Rorive G. Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 54 (2000) 218-226
16. Jamal S., Chase C., Goh Y., Richardson R., and Hawker G. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39 (2002) 843-849
17. Kaji H., Suzuki M., Yano S., et al. Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22 (2002) 325-331
18. Urena P., Bernard-Poenaru O., Ostertag A., et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18 (2003) 2325-2331
19. Inaba M., Okuno S., Kumeda Y., Yamakawa T., Ishimura E., and Nishizawa Y. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif Tissue Int 76 (2005) 256-260
20. Rix M., Andreassen H., Eskildsen P., Bente L., and Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 56 (1999) 1084-1093
21. Hsu C.Y., Cummings S.R., McCulloch C.E., and Chertow G.M. Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. Kidney Int 61 (2002) 1814-1820
22. Ishani A., Paudel M., Taylor B.C., et al. Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int 19 (2008) 1549-1556
23. Jassal S.K., von Muhlen D., and Barrett-Connor E. Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study. J Bone Miner Res 22 (2007) 203-210
24. Krieger N., Tenehouse A., Joseph L., et al. Research notes: the Canadian Multicentre Osteoporosis Study (CaMOS): background, rationale, methods. Can J Aging 18 (1999) 376-387
25. VITROS Chemistry Product: Calcium Test Methodology (2004), Ortho-Clinical Diagnostics Johnson & Johnson, Rochester, NY
26. VITROS Chemistry Product: Phosphorous Test Methodology (2004), Ortho-Clinical Diagnostics Johnson & Johnson, Rochester, NY
27. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorous. [abstract]. J Biol Chem 66 (1925) 375
28. Goromy G. A modification of the colorimetric phosphorous determination for use with a photoelectric colorimeter. [abstract]. J Lab Clin Med 27 (1942) 955
29. VITROS Chemistry Product: Creatinine Test Methodology (2004), Ortho-Clinical Diagnostics Johnson & Johnson, Rochester, NY
30. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
31. DuBois D., and Dubouis E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17 (1916) 863-871
32. Ware J.E.J. SF-36 Health Survey Manual and Interpretation Guide (1993), The Health Institute; New England Medical Center, Boston, MA
33. Kiel D. Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 10 (1995) 518-523
34. Jackson S.A., Tenenhouse A., and Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11 (2000) 680-687
35. Papaioannou A., Joseph L., Ioannidis G., et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 16 (2005) 568-578
36. Cummings S.R., Cosman F., and Jamal S.A. Osteoporosis. An Evidenced-Based Guide to Prevention and Management (2002), American College of Physicians, Philadelphia, PA
37. Yendt E.R., Cohanim M., Jarzylo S., Jones G., and Rosenberg G. Bone mass is related to creatinine clearance in normal elderly women. J Bone Miner Res 6 (1991) 1043-1050
38. Vassalotti J.A., Uribarri J., Chen S.C., et al. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51 suppl 2 (2008) S56-S68